Table S2.
Inhaler preference outcomes from using the COPD Device Preference Questionnaire in the Phase IIIb active comparator study (intent-to-treat population)
| Patients receiving active Ellipta™ N=454 | Patients receiving active HandiHaler® N=451 | |
|---|---|---|
| Number of steps, n (%) | ||
| n | 441 | 434 |
| Ellipta™ | 262 (59) | 242 (56) |
| HandiHaler® | 68 (15) | 68 (16) |
| No preference | 111 (25) | 124 (29) |
| Time needed to use, n (%) | ||
| n | 441 | 434 |
| Ellipta™ | 270 (61) | 256 (59) |
| HandiHaler® | 65 (15) | 59 (14) |
| No preference | 106 (24) | 119 (27) |
| Ease of use, n (%) | ||
| n | 441 | 434 |
| Ellipta™ | 283 (64) | 256 (59) |
| HandiHaler® | 61 (14) | 62 (14) |
| No preference | 97 (22) | 116 (27) |
Notes: N is the number of patients in the ITT population; n is the number of patients with analyzable data.
Abbreviations: COPD, chronic obstructive pulmonary disease; ITT, intent-to-treat.